search
Back to results

The Effects of Combined Gum-chewing and Parenteral Metoclopramide on Post-operative Ileus

Primary Purpose

Ileus Postoperative

Status
Completed
Phase
Phase 4
Locations
Nigeria
Study Type
Interventional
Intervention
Metoclopramide 10mg
Gum and metoclopramide
Gum
Control
Sponsored by
Ikechukwu Bartholomew Ulasi
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Ileus Postoperative focused on measuring Gum-chewing, Metoclopramide, Abdominal, Surgery

Eligibility Criteria

16 Years - 65 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: All patients requiring elective abdominal surgery aged 16-65years Exclusion Criteria: Abdominal emergency surgeries Structural or functional inability to chew gum

Sites / Locations

  • University College Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

Gum-Metoclopramide

Gum-only

Metoclopramide-only

Control

Arm Description

Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively and to chew one a stick of sugar free gum (to be chewed over 15minutes) 8 hourly till either first flatus or feces was passed

Chew one stick of sugar free gum (to be chewed over 15minutes) 8 hourly till either first flatus or feces was passed

Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively

10ml of sterile water intravenously 8hourly for the first 72hours post-operatively

Outcomes

Primary Outcome Measures

Duration of post-operative ileus
Time to either the passage of flatus or feces, assessed every 8hours from post-operative day 1

Secondary Outcome Measures

Duration of hospital stay
Length of in-hospital care after surgery

Full Information

First Posted
December 17, 2022
Last Updated
December 30, 2022
Sponsor
Ikechukwu Bartholomew Ulasi
search

1. Study Identification

Unique Protocol Identification Number
NCT05669781
Brief Title
The Effects of Combined Gum-chewing and Parenteral Metoclopramide on Post-operative Ileus
Official Title
The Effects of Combined Gum-chewing and Parenteral Metoclopramide on the Duration of Post-operative Ileus After Abdominal Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
September 30, 2019 (Actual)
Study Completion Date
September 30, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ikechukwu Bartholomew Ulasi

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
A delay in the return of bowel function is a common occurrence after abdominal surgeries.1 The goal of this study was to test the effect of the combined use of chewing a gum and administering metoclopramide intravenously on the duration of this natural delay in the return of bowel function after abdominal surgeries. Patients were grouped into four: the first group received both gum and metoclopramide; the second group received only gum; the third group received only metoclopramide, while the fourth group (the control group) received sterile water for injection. The groups were compared for the time taken for bowel function to return and the duration of hospital stay.
Detailed Description
This was a prospective randomized controlled trial that recruited all patients requiring elective abdominal surgery, aged 16-65years. Abdominal emergency surgeries and structural or functional inability to chew gum constituted the exclusion criteria. A written informed consent was obtained from all eligible patients. Considering an effect size of 0.8(Cohen, 1962)2 at a power of 80% with 95% level of confidence and type-1 error of 5%, a total sample size of 105 study participants was obtained, having considered an attrition rate of 5%. Study participants were randomized into 4 groups (a gum-metoclopramide {GM} group, a gum-only {G} group, a metoclopramide-only {M} group and a control {C} group) using blocked sequence randomization. Data was obtained through a detailed history and physical examination and include demographic variables like age and gender. Medical history of previous abdominal surgeries and any comorbidity like chronic constipation, diabetes mellitus, parkinsonism, renal or cardiac disease were sought and allergy to metoclopramide or gum noted. Body Mass Index (BMI) and relevant investigation results were recorded. Other pre- and intra-operative data recorded included: clinical diagnosis, American Society of Anaesthesiologists (ASA) grade, type of anaesthesia, cadre of surgeon, surgical access (laparoscopic versus open), length of skin incision, intra-operative blood loss, total intra-operative fluid administered, duration of surgery, surgical procedure done and duration of anaesthesia. Recorded post-operatively were time to passage of first flatus, time to passage of first feces, time to initial recording of bowel sounds, time to tolerance of normal diet, day of first ambulation, length of hospital stay, cost of hospital stay and post-operative complications. Informed consent was obtained from all patients that met the inclusion criteria. All patients for elective surgery were admitted at least a day prior to surgery and kept on nothing by mouth from 12midnight on the eve of surgery. Patients were given intravenous metronidazole and ceftriaxone at the induction of anaesthesia. All the patients had general anaesthesia. Abdominal skin incision was made by the surgeon who was either a senior registrar or consultant in general surgery and to whom the patient's group was undisclosed. Standard procedures (surgical and anesthetic) relevant for each case were carried out. The group assigned to each patient was known only to the research assistants (a house surgeon and the nursing staff) who alone administered the intervention to the appropriate groups. Although what was used for intravenous intervention was undisclosed to the patients in the GM, M and C groups, it was not possible to blind patients who received gum only (G group). All interventions were commenced from the 1st post-operative day. Patients in the gum-only(G) group were given one stick of sugar free gum (Orbit, Wrigley, US) 3 times 8 hourly daily (in the morning, afternoon and in the evening) till either first flatus or feces was passed with an instruction to chew for 15 minutes(only) without swallowing the chewed gum. The criteria for discontinuing each intervention was not disclosed to the patients. The gum was given to patients at a fixed interval to help monitor compliance. Patients in the metoclopramide-only (M) group received intravenous metoclopramide (Philometro, Hubei Tianyao) 10mg 8hourly for the first 72hours post-operatively. The gum-metoclopramide (GM) group received intravenous metoclopramide and also chewed gum using the protocol earlier described for gum only and metoclopramide only groups. Patients assigned to the control (C) group received 10ml of sterile water intravenously 8hourly for the first 72hours post-operatively. All patients were asked to notify the nursing staff at first passage of flatus. A blinded doctor visited the patients 8hourly and recorded the time of the first bowel sounds, passage of flatus, and defecation. After giving each intervention, the type and time of intervention was documented in an identifier-free patient's questionnaire. The first time of flatus and defecation was recorded based on the patient's own statements. Prolonged post-operative ileus was defined as ileus lasting more than 5days following laparotomy or greater than 3days following laparoscopic surgery.3 Nasogastric tube was removed on the day of return of bowel function. The total duration of hospital stay, calculated from the first post-operative day to the day of discharge, was recorded. The association between categorical and numerical peri-operative factors with prolonged post-operative ileus was analyzed using the Chi-square (and Fisher's exact) test and independent t-test (and Mann Whitney-U test) respectively. Comparison of groups in terms of the duration of post-operative ileus and duration of hospital stay was done using analysis of variance (ANOVA). Secondary endpoints compared between the groups included time to first bowel sound, duration of hospital stay and cost of hospital stay. Statistical significance was set at a p-value of <0.05. Version 23 of the Statistical Package for Social Sciences for Windows was used to analyze all data obtained from this study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ileus Postoperative
Keywords
Gum-chewing, Metoclopramide, Abdominal, Surgery

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Factorial Assignment
Model Description
Patients were randomized into a gum-metoclopramide (GM) group, a gum-only (G) group, a metoclopramide-only (M) group and a control (C) group. Patients in the GM group chewed gum and received intravenous metoclopramide, each 8 hourly. In the G group, patients chewed only gum while those in the M group received 10mg of intravenous metoclopramide only. To the C group, 10ml of intravenous sterile water for injection was given 8 hourly
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
105 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Gum-Metoclopramide
Arm Type
Active Comparator
Arm Description
Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively and to chew one a stick of sugar free gum (to be chewed over 15minutes) 8 hourly till either first flatus or feces was passed
Arm Title
Gum-only
Arm Type
Active Comparator
Arm Description
Chew one stick of sugar free gum (to be chewed over 15minutes) 8 hourly till either first flatus or feces was passed
Arm Title
Metoclopramide-only
Arm Type
Active Comparator
Arm Description
Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
10ml of sterile water intravenously 8hourly for the first 72hours post-operatively
Intervention Type
Drug
Intervention Name(s)
Metoclopramide 10mg
Other Intervention Name(s)
Philometro, Hubei Tianyao
Intervention Description
Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively
Intervention Type
Combination Product
Intervention Name(s)
Gum and metoclopramide
Intervention Description
Intravenous metoclopramide 10mg 8hourly for the first 72hours post-operatively and one stick of sugar-free gum (over 15minutes) 8 hourly till either the first flatus or feces was passed
Intervention Type
Other
Intervention Name(s)
Gum
Intervention Description
One stick of sugar-free gum (over 15minutes) 8 hourly till either the first flatus or feces was passed
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
10ml of sterile water intravenously 8hourly for the first 72hours post-operatively
Primary Outcome Measure Information:
Title
Duration of post-operative ileus
Description
Time to either the passage of flatus or feces, assessed every 8hours from post-operative day 1
Time Frame
From 24 hours after surgery up to the time either flatus or feces is passed, for up to 1week after surgery
Secondary Outcome Measure Information:
Title
Duration of hospital stay
Description
Length of in-hospital care after surgery
Time Frame
First post-operative day up to the day of discharge, for up to 25days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients requiring elective abdominal surgery aged 16-65years Exclusion Criteria: Abdominal emergency surgeries Structural or functional inability to chew gum
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ikechukwu B. Ulasi
Organizational Affiliation
University College Hospital, Ibadan
Official's Role
Principal Investigator
Facility Information:
Facility Name
University College Hospital
City
Ibadan
State/Province
Oyo
ZIP/Postal Code
+234
Country
Nigeria

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26231994
Citation
Pedziwiatr M, Kisialeuski M, Wierdak M, Stanek M, Natkaniec M, Matlok M, Major P, Malczak P, Budzynski A. Early implementation of Enhanced Recovery After Surgery (ERAS(R)) protocol - Compliance improves outcomes: A prospective cohort study. Int J Surg. 2015 Sep;21:75-81. doi: 10.1016/j.ijsu.2015.06.087. Epub 2015 Jul 29.
Results Reference
background
PubMed Identifier
13880271
Citation
COHEN J. The statistical power of abnormal-social psychological research: a review. J Abnorm Soc Psychol. 1962 Sep;65:145-53. doi: 10.1037/h0045186. No abstract available.
Results Reference
background
Citation
Delaney C, Kehlet H, Senagore AJ, Bauer AJ, Beart R, Billingham R, et al. Postoperative ileus: profiles, risk factors, and definitions - a framework for optimizing surgical outcomes in patients undergoing major abdominal colorectal surgery. In: Bosker G, editor. Clinical consensus update in general surgery; 2006 May 1; Massachusetts United States. Roswell (GA): Pharmatecture, LLC; 2006. p. 1-26.
Results Reference
background

Learn more about this trial

The Effects of Combined Gum-chewing and Parenteral Metoclopramide on Post-operative Ileus

We'll reach out to this number within 24 hrs